Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HDL cholesterol as a diagnostic tool for clinical differentiation of GCK-MODY from HNF1A-MODY and type 1 diabetes in children and young adults.

Clinical endocrinology - 1 Sept 2011

Fendler Wojciech, Borowiec Maciej, Antosik Karolina, Szadkowska Agnieszka, Deja Grazyna, Jarosz-Chobot Przemyslawa, Mysliwiec Malgorzata, Wyka Krystyna, Pietrzak Iwona, Skupien Jan, Malecki Maciej T, Mlynarski Wojciech

Abstract excerpt

INTRODUCTION: Confirmation of monogenic diabetes caused by glucokinase mutations (GCK-MODY) allows pharmacogenetic intervention in the form of insulin discontinuation. This is especially important among paediatric and young adult populations where GCK-MODY is most prevalent. METHODS: The study evaluated the utility of lipid parameters in screening for patients with GCK-MODY. Eighty-nine children with type 1...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cholesterol
Share to Cholesterol, HDL

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diabetes Mellitus, Type 1

Share to Diagnosis, Differential

Share to Glucokinase

Share to Hepatocyte Nuclear Factor 1-alpha

Share to Multivariate Analysis

Share to Triglycerides

Source

Identifiers

PMID: 21521320
DOI: 10.1111/j.1365-2265.2011.04052.x

Genes

GCK

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HDL cholesterol as a diagnostic tool for clinical differentiation of GCK-MODY from HNF1A-MODY and type 1 diabetes in children and young adults.PMID 21521320Read ↗

Update on clinical screening of maturity-onset diabetes of the young (MODY)Semantic proximity Read ↗

Systematic assessment of etiology in adults with a clinical diagnosis of young-onset type 2 diabetes is a successful strategy for identifying maturity-onset diabetes of the young.Semantic proximity Read ↗

Diagnosis in diabetes: does it matter?Semantic proximity Read ↗

A review of maturity onset diabetes of the young (MODY) and challenges in the management of glucokinase-MODY.Semantic proximity Read ↗

Phenotypical aspects of maturity-onset diabetes of the young (MODY diabetes) in comparison with Type 2 diabetes mellitus (T2DM) in children and adolescents: experience from a large multicentre database.Semantic proximity Read ↗

Insights from basic adjunctive examinations of GCK-MODY, HNF1A-MODY, and type 2 diabetes: A systemic review and meta-analysis.Semantic proximity Read ↗

Genetic variants and characterization of MODY in a single, large pediatric referral centerSemantic proximity Read ↗

Diagnosis and management of maturity-onset diabetes of the young.Semantic proximity Read ↗

Glucokinase-Related Maturity-Onset Diabetes of the Young in India and the Clinical Utility of the MODY Probability Calculator for Identifying Underdiagnosed and Rare FormsSemantic proximity Read ↗

Genetic testing for glucokinase mutations in clinically selected patients with MODY: a worthwhile investment.Semantic proximity Read ↗

Prevalence of monogenic diabetes in the population-based Norwegian Childhood Diabetes Registry.Semantic proximity Read ↗

Half of clinically defined maturity-onset diabetes of the young patients in Denmark do not have mutations in HNF4A, GCK, and TCF1.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.